CTSA INFRASTRUCTURE FOR AIDS RESEARCH

本分项目是CTSA供资的估计百分比，即 被用于广泛的研究领域(艾滋病研究、儿科研究或 临床试验)。列出的总成本仅是对CTSA金额的估计 用于这一研究领域的基础设施，而不是由 授予子项目或子项目工作人员的NCRR补助金。 由于一项成功的生物医学研究工作，在理解病理过程和开发曾经无法治愈的疾病的新疗法方面取得了长足的进步。尽管如此，在更有效和更多产的研究道路上仍有障碍。由于不同学科的研究人员之间缺乏有效和有力的沟通渠道，专业化程度提高，有抱负的研究人员的教育和职业发展道路没有得到很好的规划，合作研究也没有得到目前的供资办法或内部促进委员会的承认或鼓励。为了改变纽约大学进行研究的方式，并提高研究工作的质量和生产率，我们建议纽约大学和纽约市卫生与医院公司建立一个临床和转化科学研究所(CTSI)，该研究所将有以下目标：1)加强纽约大学各学院临床、翻译和基础科学家之间的合作，以更好地确定科学进步与临床问题的相关性和适用性；2)提供领导、基础设施和资源，以支持新科学以及快速、高效和安全地将科学发现应用于社区；3)支持教育、培训和发展研究人员，使他们能够进行必要的研究，为公众带来科学进步；4)加强纽约大学研究机构与社区的联系，以便更快地识别健康问题，调查其科学基础，应用所获得的知识，并促进社区对新发展和循证医学的利用，并减少医疗保健差距。CTSI将把纽约大学(一所提供公共服务的私立大学)与卫生与医院公司(一家致力于为纽约市所有人提供卓越护理的公共机构)联系起来，成立一家新的企业，旨在利用他们的资源来应对纽约和美国在21世纪面临的健康问题。相关性(见说明)：我们建议两个伟大的组织合作，创建一个独特的翻译和临床研究中心，纽约大学-纽约市卫生与医院公司临床和翻译科学研究所(NYU-HHC CTSI)。纽约大学-HHC CTSI结合了研究、患者护理和社区推广方面的巨大优势和协同效应，将提供一个新的创新引擎，将医学进步从实验室转化为患者，并从患者转化为社区。

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. Due to a successful biomedical research effort great strides have been made in understanding pathologic processes and developing new therapies for once untreatable diseases. Nonetheless, there are speed bumps on the road to more efficient and productive research. Increased specialization with less effective and robust lines of communication among researchers in different disciplines, the educational and career development pathways for aspiring researchers are not well delineated and collaborative research has not been recognized or encouraged by current funding approaches or internal promotion committees. To transform the way that research is carried out at NYU and to enhance the quality and productivity of the research effort we propose a partnership between New York University and New York City Health and Hospitals Corporation to establish a Clinical and Translational Science Institute (CTSI) that will have the following aims: 1) To increase collaboration among clinical, translational and basic scientists across the colleges and schools of NYU to better determine the relevance and applicability of scientific advances to clinical problems; 2) To provide the leadership, infrastructure and resources to support novel science and the rapid, efficient and safe application of scientific discoveries to the community; 3) To support the education, training and development of researchers who can carry on the investigations necessary to bring scientific advances to the public; 4) To enhance the ties between the research establishment at NYU and the community so as to more rapidly identify health problems, investigate their scientific basis, apply the knowledge gained and promote utilization of new developments and evidence based medicine by the community, and to reduce healthcare disparities. The CTSI will link NYU, "a private university in public service," with Health and Hospitals Corporation, a public agency devoted to outstanding care for all individuals in New York City, in a new venture designed to bring their resources to bear on the health problems facing New York and the nation in the 21st Century. RELEVANCE (See instructions): We propose a partnership of two great organizations to create a unique center for translational and clinical research, the New York University-New York City Health & Hospitals Corporation Clinical and Translational Science Institute (NYU-HHC CTSI). Combining great strengths and synergies in research, patient care and community outreach, the NYU-HHC CTSI will provide a new and innovative engine for translation of medical advances from the laboratory to the patient and from the patient to the community.